Therapy News and Research

RSS

State roundup: Ga. hospital fee bill nears passage

After a series of friendly questions and statements of support, the fast-tracked legislation on a state hospital provider fee swept through a House committee Tuesday. The House Government Affairs Committee, by a 15-1 vote, approved Senate Bill 24, which would facilitate the renewal of the assessment. The state Senate passed the bill earlier this month. The legislation could reach the House floor Thursday or Friday. If it passes, it then would go to Gov. Nathan Deal for his signature -- an unusually rapid journey into law.

31 Jan 2013

Being married and cohabiting reduces risk of heart attack in both men and women in all age groups

A large population-based study from Finland has shown that being unmarried increases the risk of fatal and non-fatal heart attack in both men and women whatever their age. Conversely, say the study investigators, especially among middle-aged couples, being married and cohabiting are associated with "considerably better prognosis of acute cardiac events both before hospitalization and after reaching the hospital alive".

31 Jan 2013

No added benefit from linagliptin in patients with type 2 diabetes

Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.

31 Jan 2013

DSMB recommends continuation of CTI’s OPAXIO Phase 3 trial on ovarian cancer

Cell Therapeutics, Inc. (CTI) today announced that the Gynecologic Oncology Group (GOG) informed CTI that an independent Data Safety Monitoring Board (DSMB) recommended continuation of the GOG-0212 Phase 3 clinical trial of OPAXIOTM (paclitaxel poliglumex) as maintenance therapy in ovarian cancer with no changes following a planned interim survival analysis.

31 Jan 2013

Existing cardiomyocytes contribute to formation of new heart cells after attack

Injecting specialized cardiac stem cells into a patient's heart rebuilds healthy tissue after a heart attack, but where do the new cells come from and how are they transformed into functional muscle?

31 Jan 2013

NSU's College of Osteopathic Medicine receives approval for new medical specialty

Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.

31 Jan 2013

Mount Sinai to initiate immunological therapy trial against chronic pulmonary sarcoidosis

Patients are currently being enrolled in the first clinical trial to investigate the efficacy of immunological therapy for chronic pulmonary sarcoidosis. The trial is being conducted by researchers at the Icahn School of Medicine at Mount Sinai.

31 Jan 2013

No proof of added benefit from aclidinium bromide in adults with COPD

The drug aclidinium bromide has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG).

31 Jan 2013

No added benefit from perampanel in patients with epileptic fits

The drug perampanel has been approved since July 2012 as adjunctive therapy for adults and children aged 12 years and older with epileptic fits (seizures).

30 Jan 2013

Clarient adopts QIAGEN’s therascreen KRAS test to diagnose colorectal cancer

QIAGEN N.V. today announced that Clarient - a GE Healthcare Company and leading provider of cancer laboratory testing services in the United States - has adopted the use of the therascreen KRAS RGQ PCR Kit (therascreen KRAS test) as a companion diagnostic to guide the use of Erbitux (cetuximab) as a treatment in patients with metastatic colorectal cancer.

From QIAGEN Manchester Limited 30 Jan 2013

UCSD molecular biologist to receive Charles Rodolphe Brupbacher Prize for Cancer Research

Molecular biologist Michael Karin is to receive this year's Charles Rodolphe Brupbacher Prize for Cancer Research in recognition of his studies on the role of chronic inflammation in the development of tumors. The award, which carries CHF 100,000 in prize money, is considered one of the highest accolades for cancer researchers worldwide. The awards ceremony takes place in Zurich this Thursday in the framework of an international symposium on "Breakthroughs in Cancer Research and Therapy".

30 Jan 2013

Researchers create CoQ9-deficient mutant mouse model with mitochondrial encephalomyopathy

At three to six months of life, this genetic alteration in mice -similar to that occurred in human- causes a rapid degeneration in the lower limbs to death for cardiac arrest.

30 Jan 2013

Massage therapy can lower blood pressure, help prevent colds and enhance skin tone

Massage therapy can lower blood pressure, help prevent colds, enhance skin tone and more, according to an expert at the University of Alabama at Birmingham (UAB).

30 Jan 2013

Noninvasive, drugless therapy may help mitigate symptoms associated with neurological conditions

With the infusion of an additional $1 million of financial support from The Susanne Marcus Collins Foundation, Inc., Atlanta, GA, Wake Forest Baptist Medical Center researchers are expanding their studies using a noninvasive, drugless therapy that may help to mitigate symptoms associated with a list of neurological conditions.

30 Jan 2013

Insight into reasons why precocious puberty occurs in females

New research from Oregon Health & Science University has provided significant insight into the reasons why early-onset puberty occurs in females.

30 Jan 2013

HIV-positive patients have higher incidence of non-melanoma skin cancers

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.

30 Jan 2013

FBH1 gene helps turn up the effect of chemotherapy

Chemotherapy is one of the most common treatments for cancer patients. However, many patients suffer from serious side-effects and a large proportion does not respond to the treatment. Researchers from the Biotech Research and Innovation Centre (BRIC) and Center for Healthy Aging, University of Copenhagen, now show that the gene FBH1 helps turn up the effect of chemotherapy.

30 Jan 2013

Therapy News and Research

State roundup: Ga. hospital fee bill nears passage

Being married and cohabiting reduces risk of heart attack in both men and women in all age groups

No added benefit from linagliptin in patients with type 2 diabetes

DSMB recommends continuation of CTI’s OPAXIO Phase 3 trial on ovarian cancer

Existing cardiomyocytes contribute to formation of new heart cells after attack

NSU's College of Osteopathic Medicine receives approval for new medical specialty

Mount Sinai to initiate immunological therapy trial against chronic pulmonary sarcoidosis

No proof of added benefit from aclidinium bromide in adults with COPD

No added benefit from perampanel in patients with epileptic fits

Clarient adopts QIAGEN’s therascreen KRAS test to diagnose colorectal cancer

UCSD molecular biologist to receive Charles Rodolphe Brupbacher Prize for Cancer Research

Researchers create CoQ9-deficient mutant mouse model with mitochondrial encephalomyopathy

Massage therapy can lower blood pressure, help prevent colds and enhance skin tone

Noninvasive, drugless therapy may help mitigate symptoms associated with neurological conditions

Insight into reasons why precocious puberty occurs in females

HIV-positive patients have higher incidence of non-melanoma skin cancers

FBH1 gene helps turn up the effect of chemotherapy

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Phenformin decreases size of lung tumors and increases survival in mice

Hyperbaric oxygen treatment new player in stroke rehabilitation

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News